RWM
RIGL icon

Ritholtz Wealth Management’s Rigel Pharmaceuticals RIGL Stock Holding History

Ritholtz Wealth Management’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.69M Buy
94,450
+16,064
+20% +$495K 0.06% 257
2026
Q1 		$2.12M Sell
78,386
-2,207
-3% -$74.2K 0.04% 365
2025
Q4 		$3.45M Buy
80,593
+72,999
+961% +$2.75M 0.06% 221
2025
Q3 		$215K Buy
+7,594
New +$227K ﹤0.01% 954

Other funds holding RIGL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Ritholtz Wealth Management's RIGL Position: Q2 2026 in Review

Ritholtz Wealth Management increased its Rigel Pharmaceuticals (RIGL) stake by 20% in Q2 2026, buying an estimated $495K and bringing the position to 94,450 shares worth $3.69M. The position accounts for 0.06% of the portfolio, ranked #257.

Ritholtz Wealth Management first reported a position in RIGL in Q3 2025 and has held it in 4 quarters since. 156 funds tracked by Wall St. Rank hold RIGL as of Q2 2026.

  • Ritholtz Wealth Management held 94,450 shares of Rigel Pharmaceuticals worth $3.69M as of Q2 2026.
  • Ritholtz Wealth Management bought 16,064 Rigel Pharmaceuticals shares in Q2 2026, an estimated $495K.
  • Rigel Pharmaceuticals made up 0.06% of Ritholtz Wealth Management's portfolio in Q2 2026, its #257 holding.
  • Ritholtz Wealth Management first reported a position in Rigel Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • 156 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q2 2026.

Based on Ritholtz Wealth Management's 13F filing for Q2 2026, filed 10 Aug 2026.